Bioconjugate Chemistry · 2010 · 33 citations · 28 references
MedicineCancer BiologyOncologyCarcinogenesisGene ExpressionMolecular Cell BiologyCancer EpigeneticsDna MethylationEpigenetic Alterations In CancerEpigenetic Regulation In CancerPromoter RegulationCell-type Specific MethylationDna Methylation ModulationDna MethyltransferasesGreen Fluorescent Protein ReportersOncogenic DysregulationOncogenic TransformationPromoter MethylationTumor Initiating Cells
The epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein that has been identified as a marker of cancer-initiating cells. EpCAM is highly expressed on most carcinomas, and transient silencing of EpCAM expression leads to reduced oncogenic potential. To silence the EpCAM gene in a persistent manner via targeted DNA methylation, a low activity mutant (C141S) of the CpG-specific DNA methyltransferase M.SssI was coupled to a triple-helix-forming oligonucleotide (TFO-C141S) specifically designed for the EpCAM gene. Reporter plasmids encoding the green fluorescent protein under control of different EpCAM promoter fragments were treated with the TFO-C141S conjugate to determine the specificity of targeted DNA methylation in the context of a functional EpCAM promoter. Treatment of the plasmids with TFO-C141S resulted in efficient and specific methylation of the targeted CpG located directly downstream of the triple helix forming site (TFS). No background DNA methylation was observed neither in a 700 bp region of the EpCAM promoter nor in a 400 bp region of the reporter gene downstream of the TFS. Methylation of the target CpG did not have a detectable effect on promoter activity. This study shows that the combination of a specific TFO and a reduced activity methyltransferase variant can be used to target DNA methylation to predetermined sites with high specificity, allowing determination of crucial CpGs for promoter activity.
28
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text
Medicine, Cell Biology, Oncology +11
Identification of Pancreatic Cancer Stem Cells
Chenwei Li, David G. Heidt, Piero Dalerba et al. · Cancer Research · 2007 · 3.4K citations · Full text
Medicine, Cell Biology, Oncology +17
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba, Scott J. Dylla, In-Kyung Park et al. · Proceedings of the National Academy of Sciences · 2007 · 2.2K citations · Full text
Medicine, Cell Biology, Oncology +17
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel, Sabine Denzel, Brigitte Mack et al. · Nature Cell Biology · 2009 · 727 citations
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Taro Yamashita, Marshonna Forgues, Wei Wang et al. · Cancer Research · 2008 · 715 citations · Full text